OUTCOMES OF DIABETIC PATIENTS UNDERGOING PCI WITH CONTEMPORARY DRUG-ELUTING STENTS: ANALYSIS FROM THE BIONICS STUDY

Patients with diabetes mellitus and coronary artery disease are at increased risk for adverse cardiovascular events after PCI. We sought to investigate the impact of diabetes on outcomes following implantation of contemporary DES in the BioNIR Ridaforolimus-eluting coronary stent system in Coronary